Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2026-02-17 @ 10:54 PM
Study NCT ID:
NCT00589550
Status:
TERMINATED
Last Update Posted:
2015-06-08
First Post:
2008-01-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer
Sponsor:
Thomas Olencki
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
OSU-06113
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |